Dendrimer-based RNA interference delivery for cancer therapy

Leyuan Xu, W. Andrew Yeudall, Hu Yang

Research output: Chapter in Book/Report/Conference proceedingConference contribution

10 Scopus citations


RNA interference (RNAi) has emerged as a promising tool for cancer treatment. A strenuous ongoing effort for translation of RNAi into clinically acceptable therapy is the development of vectors for efficient and targeted RNAi delivery. In this chapter, we review RNAi-based cancer treatment and the utility of dendrimers in RNAi delivery.

Original languageEnglish (US)
Title of host publicationTailored Polymer Architectures for Pharmaceutical and Biomedical Applications
PublisherAmerican Chemical Society
Number of pages17
ISBN (Print)9780841227989
StatePublished - Jul 8 2013
Externally publishedYes

Publication series

NameACS Symposium Series
ISSN (Print)0097-6156
ISSN (Electronic)1947-5918

ASJC Scopus subject areas

  • Chemistry(all)
  • Chemical Engineering(all)


Dive into the research topics of 'Dendrimer-based RNA interference delivery for cancer therapy'. Together they form a unique fingerprint.

Cite this